Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway

被引：2
作者：
Gartner, Fabian [1 ]
Assmus, Jorg [2 ]
Flotten, Oystein [1 ,3 ]
Ramnefjell, Maria Paula [4 ,5 ]
Aanerud, Marianne [1 ,3 ]
机构：
[1] Haukeland Hosp, Dept Thorac Med, Postboks 1400, NO-5021 Bergen, Norway
[2] Haukeland Hosp, Ctr Clin Res, Bergen, Norway
[3] Univ Bergen, Dept Clin Sci, Fac Med, Bergen, Norway
[4] Haukeland Hosp, Dept Pathol, Bergen, Norway
[5] Univ Bergen, Dept Clin Med, Fac Med, Bergen, Norway
来源：
ACTA ONCOLOGICA | 2022年 / 61卷 / 07期
关键词：
NIVOLUMAB; DOCETAXEL; IMMUNOTHERAPY; OUTCOMES;
D O I：
10.1080/0284186X.2022.2068969
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：814 / 818
页数：5
相关论文
共 28 条
[1]   SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626
[2]   Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience [J].
Areses Manrique, Ma Carmen ;
Mosquera Martinez, Joaquin ;
Garcia Gonzalez, Jorge ;
Afonso Afonso, Francisco Javier ;
Lazaro Quintela, Martin ;
Fernandez Nunez, Natalia ;
Azpitarte Raposeiras, Cristina ;
Amenedo Gancedo, Margarita ;
Santome Couto, Lucia ;
Garcia Campelo, Ma Rosario ;
Munoz Iglesias, Jose ;
Cortegoso Mosquera, Alexandra ;
Vilchez Simo, Rocio ;
Casal Rubio, Joaquin ;
Campos Balea, Begona ;
Carou Frieiro, Iria ;
Alonso-Jaudenes Curbera, Guillermo ;
Anido Herranz, Urbano ;
Garcia Mata, Jesus ;
Firvida Perez, Jose Luis .
TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (03) :404-415
[3]   Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].
Borghaei, H. ;
Paz-Ares, L. ;
Horn, L. ;
Spigel, D. R. ;
Steins, M. ;
Ready, N. E. ;
Chow, L. Q. ;
Vokes, E. E. ;
Felip, E. ;
Holgado, E. ;
Barlesi, F. ;
Kohlhaeufl, M. ;
Arrieta, O. ;
Burgio, M. A. ;
Fayette, J. ;
Lena, H. ;
Poddubskaya, E. ;
Gerber, D. E. ;
Gettinger, S. N. ;
Rudin, C. M. ;
Rizvi, N. ;
Crino, L. ;
Blumenschein, G. R. ;
Antonia, S. J. ;
Dorange, C. ;
Harbison, C. T. ;
Finckenstein, F. Graf ;
Brahmer, J. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639
[4]   Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population [J].
Brzezianska, Ewa ;
Karbownik, Malgorzata ;
Migdalska-Sek, Monika ;
Pastuszak-Lewandoska, Dorota ;
Wloch, Jan ;
Lewinski, Andrzej .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 599 (1-2) :26-35
[5]   The immune system and aging: a review [J].
Castelo-Branco, Camil ;
Soveral, Iris .
GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (01) :16-22
[6]   Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands [J].
Cramer-van der Welle, Christine M. ;
Verschueren, Marjon V. ;
Tonn, Merel ;
Peters, Bas J. M. ;
Schramel, Franz M. N. H. ;
Klungel, Olaf H. ;
Groen, Harry J. M. ;
van de Garde, Ewoudt M. W. .
SCIENTIFIC REPORTS, 2021, 11 (01)
[7]   ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors-A systematic review and meta-analysis of real world data [J].
Dall'Olio, Filippo G. ;
Maggio, Ilaria ;
Massucci, Maria ;
Mollica, Veronica ;
Fragomeno, Benedetta ;
Ardizzoni, Andrea .
LUNG CANCER, 2020, 145 :95-104
[8]   Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: A prognostic score from individual data of nine randomised trials [J].
Di Maio, Massimo ;
Lama, Nicola ;
Morabito, Alessandro ;
Smit, Egbert F. ;
Georgoulias, Vassilis ;
Takeda, Koji ;
Quoix, Elisabeth ;
Hatzidaki, Dora ;
Wachters, Floris M. ;
Gebbia, Vittorio ;
Tsai, Chun-Ming ;
Camps, Carlos ;
Schuette, Wolfgang ;
Chiodini, Paolo ;
Piccirillo, Maria Carmela ;
Perrone, Francesco ;
Gallo, Ciro ;
Gridelli, Cesare .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) :735-743
[9]   Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study [J].
Garon, Edward B. ;
Hellmann, Matthew D. ;
Rizvi, Naiyer A. ;
Carcereny, Enric ;
Leighl, Natasha B. ;
Ahn, Myung-Ju ;
Eder, Joseph Paul ;
Balmanoukian, Ani S. ;
Aggarwal, Charu ;
Horn, Leora ;
Patnaik, Amita ;
Gubens, Matthew ;
Ramalingam, Suresh S. ;
Felip, Enriqueta ;
Goldman, Jonathan W. ;
Scalzo, Cathie ;
Jensen, Erin ;
Kush, Debra A. ;
Hui, Rina .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (28) :2518-+
[10]   Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries [J].
Green, Angela K. ;
Curry, Michael ;
Trivedi, Niti ;
Bach, Peter B. ;
Mailankody, Sham .
JAMA NETWORK OPEN, 2021, 4 (02)
123